참고문헌
- Evans R. Macrophage requirement for growth of a murine fibrosarcoma. Br J Cancer 1978;37:1086-9
- Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996;56:4625-9
- Del Prete G, De Carli M, Ricci M, Romagnani S. Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th 1 clones is limited by their cytolytic capacity. J Exp Med 1991;174:809-13
- Asselin-Paturel C, Echchakir H, Carayol G. Gay F, Opolon P, Grunerwald P. et al Quantitative analysis of Th1, Th2 and TGF-beta 1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int J Cancer 1998; 77:7-12
- Ren Z, Pang G, Clancy R. Gastric carcinoma: T cell response and vascularity. Shift of the gastric T-cell response in gastric carcinoma. J Gastroenterol Hepatol 2001;16:142-8
- Hasturk S, Kemp B, Kalapurakal SK, Kurie JM, Hong WK, Lee JS. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Cancer. 2002;94:1023-31
- Blaine SA, Wick M, Dessev C, Nemenoff RA. Induction of cPLA2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun. J Biol Chem. 2001;276:42737-43
- Callejas NA, Casado M, Diaz-Guerra MJ, Bosca L, Martin-Sanz P. Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology. 2001;33:860-7
- Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med. 2002;8:289-93
- Sharma S, Stolina M, Yang SC, Baratelli F, Lin JF, Dubinett SM. et al. Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. Clin Cancer Res. 2003;9:961-8
- Peri A, Cordella-Miele E, Miele L Mukherjee AB. Tissue-specific expression of the gene coding for human Clara cell 10-kD protein, a phospholipase A2-inhibitory protein. J Clin Invest 1993;92:2099-109
- Mukherjee AB, Kundu GC and Mantile-Selvaggi G. 5uan CJ Mandal AK Chaltopadrhyay s, et al. Uteroglobin: a novel cytokine? Cell Mol. Life Sci. 1999;55:771-87
- Miele L, Cordella-Miele E, Mukherjee AB. Uteroglobin: structure, molecular biology, and new perspectives on its function as a phospholipase A2 inhibitor Endocr Rev. 1987:8:474-90
- Levin SW, Butler JD, Schumacher UK, Wingtman PD, Mukherjee AB. Uteroglobin inhibits phospholipase A2 activity. Life Sci. 1986;38:1813-9
- Zhang Z, Zimonjic DB, Popsecu NC. Wang N, Geruard DS, Stone EM, et al. Human uteroglobin gene:structure, subchromosomal localization, and polymorphism. DNA Cell Biol. 1997;16:73-83
- Mukherjee AB, Ulane RE, Agrawal AK. Role of uteroglobin and transglutaminase in masking the antigenicity of implanting rabbit embryos. Am J Reprod Immunol. 1982;2:135-41
- Sheng H, Shao J, Morrow J D, Beauchamp R D, DuBois R N, Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 1998;58:362–6
- Tsujii M, DuBois R N, Alterations in cellular Adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995;83:493–501
- Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois R N, Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93:705–16
- Plescia O J, Smith A H, Grinwich K, Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl AcAd Sci. USA 1975; 72:1848–51
- Lala P K, Elkashab M, Kerbel R S, Parhar R S. Cure of human melanoma lung metastases in nude mice with chronic indomethacin therapy combined withmultiple rounds of IL-2: Characteristics of killer cells generated in situ. Int Immunol. 1990; 2:1149-58
- Mertens W C, Bramwell V H, Banerjee D, Gwardry-Sridhar F, Lala P K, et al. Sustained indomethacin and ranitidine with intermittent continuous infusion Interleukin-2 in advanced malignant melanoma: a phase Ⅱ study. Clin Oncol R coll Radiol 1993;5:107-13
- Smith D R, Kunkel SL, Burdick MD. Wuke CA, Owinger MB, Whyte RI, et al. Strieter. Production of Interleukin-10 by human bronchogenic carcinoma. Am J Pathol. 1994;145:18-25
-
Lee, P., M. Huang, J. Wang, S. Sharma and S. M. Dubinett. TGF-
\beta specific antisense phosphorothioate oligonucleotides abrogate lung tumor-associated immunosuppression. J. Immunol. 1994;152:3222-30 - Funahashi A, Harland RW, LeFever A. Association of increased prostaglandin E2 content in bronchoalveolar lavage fluid and intrathoracic malignancy. Chest. 1994;106:166-72
- Alleva DG, Burger CJ, Elgert KD. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10,TGF-beta, and prostaglandin E2. J Immunol. 1994;153:1674-86
- Young MR, Wright MA, Matthews JP, Malik I, Prechel M. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide. J Immunol. 1996;156:1916-22
- Kambayashi T, Alexander HR, Fong M, Strassmann G. Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derivedprostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10. J Immunol. 1995;154:3383-90
- Huang M., Sharma S., Mao J., T. And Dubinett S. M. Non-swall cell lung cancedr-derived soluble mediators and prostagladin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J Immunol. 1996;157:5512-20
- van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J ExpMed. 1995;181:775-9
- Strassmann G, Patil-Koota V, Finkelman F, Fong M, Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med. 1994;180:2365-70
- Huang M, Wang J, Lee P, Sharma S, Mao JT, Meissner H, et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 1995;55:3847-53
- Yamamura M, Modlin RL, Ohmen JD, Moy RL. Local expression of antiinflammatory cytokines in cancer. J Clin Invest. 1993;91:1005-10
- Smyth GP, Stapleton PP, Barden CB, Mestre JR, Freeman TA, Duff MD, et al. Renal cell carcinoma induces prostaglandin E2 and T-helper type 2 cytokine production in peripheral blood mononuclear cells. Ann Surg Oncol. 2003; 10:455-62
- Lee JC, Park KH, Han SJ, Yoo CG, Lee CT, Han SK, et al. Inhibitory effect of Ad- uteroglobin transduction on the growth of lung cancer cell lines. Cancer GeneTherapy. 2003;10:287-93